Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Clinical trial NCT04609046 · RECRUITING
Trial details
- NCT number
- NCT04609046
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2027-04-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.